- Home
- RLAY vs CNOB Comparison
RLAY vs CNOB Comparison
Compare RLAY & CNOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RLAY | CNOB |
|---|---|---|
| Founded | 2015 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | 2020 | 1996 |
Fundamental Metrics
Financial Performance| Metric | RLAY | CNOB |
|---|---|---|
| Price | $8.66 | $27.81 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 2 |
| Target Price | $16.00 | ★ $29.50 |
| AVG Volume (30 Days) | ★ 2.3M | 307.4K |
| Earning Date | 11-06-2025 | 01-29-2026 |
| Dividend Yield | N/A | ★ 2.61% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.30 |
| Revenue | $8,355,000.00 | ★ $295,956,000.00 |
| Revenue This Year | $20.47 | $47.80 |
| Revenue Next Year | N/A | $29.35 |
| P/E Ratio | ★ N/A | $21.21 |
| Revenue Growth | N/A | ★ 19.03 |
| 52 Week Low | $1.78 | $20.61 |
| 52 Week High | $9.04 | $28.47 |
Technical Indicators
Market Signals| Indicator | RLAY | CNOB |
|---|---|---|
| Relative Strength Index (RSI) | 66.27 | 66.51 |
| Support Level | $7.95 | $27.45 |
| Resistance Level | $9.04 | $28.47 |
| Average True Range (ATR) | 0.50 | 0.67 |
| MACD | 0.03 | 0.08 |
| Stochastic Oscillator | 75.93 | 77.21 |
Price Performance
Historical ComparisonAbout RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About CNOB ConnectOne Bancorp Inc.
ConnectOne Bancorp Inc is a community-based, full-service New Jersey-chartered commercial bank. Substantially all loans are secured with various types of collateral, including business assets, consumer assets and commercial/residential real estate. Each borrower's ability to repay its loans is dependent on the conversion of assets, cash flows generated from the borrowers' business, real estate rental and consumer wages.